Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection.
Saved in:
| Title: | Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. |
|---|---|
| Authors: | Warner BM; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Vendramelli R; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Boese AS; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tailor N; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Meilleur C; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Glowach N; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Willman M; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Truong T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Moffat E; National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Kosak B; Orion Biotechnology Polska, Krakow, Poland., Dhanidina I; Orion Biotechnology, Ottawa, Ontario, Canada., Engstrom J; Orion Biotechnology, Ottawa, Ontario, Canada., Korczak B; Orion Biotechnology Polska, Krakow, Poland., McGowan I; Orion Biotechnology Polska, Krakow, Poland., Embury-Hyatt C; National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada., Kobasa D; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada. |
| Source: | PloS one [PLoS One] 2025 Feb 05; Vol. 20 (2), pp. e0316952. Date of Electronic Publication: 2025 Feb 05 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39908288 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Warner+BM%22">Warner BM</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Vendramelli+R%22">Vendramelli R</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Boese+AS%22">Boese AS</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Audet+J%22">Audet J</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Tailor+N%22">Tailor N</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Meilleur+C%22">Meilleur C</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Glowach+N%22">Glowach N</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.<br /><searchLink fieldCode="AU" term="%22Willman+M%22">Willman M</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.<br /><searchLink fieldCode="AU" term="%22Truong+T%22">Truong T</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Moffat+E%22">Moffat E</searchLink>; National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Tierney+K%22">Tierney K</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Kosak+B%22">Kosak B</searchLink>; Orion Biotechnology Polska, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Dhanidina+I%22">Dhanidina I</searchLink>; Orion Biotechnology, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Engstrom+J%22">Engstrom J</searchLink>; Orion Biotechnology, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Korczak+B%22">Korczak B</searchLink>; Orion Biotechnology Polska, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22McGowan+I%22">McGowan I</searchLink>; Orion Biotechnology Polska, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Embury-Hyatt+C%22">Embury-Hyatt C</searchLink>; National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Kobasa+D%22">Kobasa D</searchLink>; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2025 Feb 05; Vol. 20 (2), pp. e0316952. <i>Date of Electronic Publication: </i>2025 Feb 05 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39908288 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0316952 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0316952 Titles: – TitleFull: Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Warner BM – PersonEntity: Name: NameFull: Vendramelli R – PersonEntity: Name: NameFull: Boese AS – PersonEntity: Name: NameFull: Audet J – PersonEntity: Name: NameFull: Tailor N – PersonEntity: Name: NameFull: Meilleur C – PersonEntity: Name: NameFull: Glowach N – PersonEntity: Name: NameFull: Willman M – PersonEntity: Name: NameFull: Truong T – PersonEntity: Name: NameFull: Moffat E – PersonEntity: Name: NameFull: Tierney K – PersonEntity: Name: NameFull: Kosak B – PersonEntity: Name: NameFull: Dhanidina I – PersonEntity: Name: NameFull: Engstrom J – PersonEntity: Name: NameFull: Korczak B – PersonEntity: Name: NameFull: McGowan I – PersonEntity: Name: NameFull: Embury-Hyatt C – PersonEntity: Name: NameFull: Kobasa D IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 02 Text: 2025 Feb 05 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 20 – Type: issue Value: 2 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |